Catalyst Pharmaceuticals Inc (CPRX)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 71,410 | 83,079 | 39,482 | 74,983 | 31,875 |
Revenue | US$ in thousands | 398,204 | 214,203 | 140,833 | 119,073 | 102,306 |
Net profit margin | 17.93% | 38.79% | 28.03% | 62.97% | 31.16% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $71,410K ÷ $398,204K
= 17.93%
Catalyst Pharmaceuticals Inc's net profit margin has displayed fluctuations over the past five years. The net profit margins were 17.93% in 2023, 38.79% in 2022, 28.03% in 2021, 62.97% in 2020, and 31.16% in 2019. The significant decrease in net profit margin from 2020 to 2021 stands out as a notable change in profitability efficiency. Further analysis into the company's cost structure, revenue streams, and operational performance may be warranted to understand the underlying reasons for these fluctuations in net profit margin.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
Catalyst Pharmaceuticals Inc
CPRX
17.93%
Abbott Laboratories
ABT
14.51%
AbbVie Inc
ABBV
8.95%
Alkermes Plc
ALKS
21.69%
Amphastar P
AMPH
21.34%
ANI Pharmaceuticals Inc
ANIP
4.13%
Arcus Biosciences Inc
RCUS
-262.39%
Biomarin Pharmaceutical Inc
BMRN
7.06%
Bristol-Myers Squibb Company
BMY
17.83%
Catalent Inc
CTLT
-23.81%
Collegium Pharmaceutical Inc
COLL
10.47%